In-house IP roundup: UK Actavis ruling raises clarity on dosage regimen patents; how businesses get software patents; Google and Avon reveal portfolio management strategies

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house IP roundup: UK Actavis ruling raises clarity on dosage regimen patents; how businesses get software patents; Google and Avon reveal portfolio management strategies

Money

Managing IP rounds up the latest news and analysis from patent-focused businesses

Drugs

UK Actavis ruling raises clarity on dosage regimen patents, say drug companies

Innovator and generics businesses say that the UK Supreme Court’s ruling in Actavis v Icos and the guidelines it produced give them greater insight into whether a dosage regimen would be considered obvious. Read more ...









Drugs

How businesses get software patents

Counsel at Amadeus, IBM, a tech company and a bank reveal how they give themselves the best chance of getting software patent protection through better communication with engineers and storytelling with patent examiners. Read more ... 











Google

Google and Avon: ask hard questions to get the most out of your portfolios

Senior patent counsel at one of the world’s biggest makeup companies and a tech giant delve into their sometimes cut-throat tactics for shaping their patent portfolios and the cost-saving drivers behind them. Read more ... 











Money

Blockchain: patent counsel reveal approaches to decentralised ledgers

In-house lawyers from Citigroup, Nevro and Etsy share their thoughts on blockchain strategies and how registrations might be disrupted by eligibility issues. Read more ... 









Sign up to receive more content like this in Patent Strategy’s weekly newsletter.



more from across site and SHARED ros bottom lb

More from across our site

A $110 million US verdict against Apple and an appellate order staying a $39 million trademark infringement finding against Amazon were also among the top talking points
Attorneys are watching how AI affects trademark registrations and whether a SCOTUS ruling from last year will have broader free speech implications
Patent lawyers explain why they will be keeping an eye on the implications of a pharma case and on changes at the USPTO in the second half of 2025
The insensitive reaction to a UK politician crying on TV proves we have a long way to go before we can say we are tackling workplace wellbeing
Adrian Percer says he was impressed by the firm’s work on billion-dollar cases as well as its culture
In our latest interview with women IP leaders, Catherine Bonner at Murgitroyd discusses technology, training, and teaching
Developments included an update in the VAR dispute between Ballinno and UEFA, the latest CMS updates, and a swathe of market moves
The LMG Life Sciences Americas Awards is thrilled to present the 2025 shortlist
A new order has brought the total security awarded to a Canadian tech company to $45 million, the highest-ever by an Indian court in an IP case
Andrew Blattman reflects on how IP practices have changed and shares his hopes for increased AI use and better performance on the stock market
Gift this article